Last year, Dr Carolin Schumacher joined our team as the new Chief Executive. She recently sat down with industry magazine Animal Pharm to talk about her aspirations and  how she […]

To commemorate the 2019 World Veterinary Day whose theme was the Value of Vaccination, the Veterinary Social Business (VSB) division of Hester Biosciences Limited, a GALVmed partner in South Asia, […]

Inaugural scientific workshop held from 19-20 March 2019 in Nairobi, Kenya During the Keystone Symposia in Cape Town (2016) African scientists set the base for establishing the African Vaccinology Network […]

GALVmed partner, Hester Biosciences Ltd, has officially launched its animal health manufacturing plant in Nepal. The facility is expected to boost Hester’s role in providing animal health products to smallholder […]

Warm greetings and best wishes for a successful and prosperous 2019! While the New Year is still young, I would like to share with you some of the key moments […]

GALVmed, with its partner Hester Bioscience Limited has signed a new Memorandum of Understanding (MoU) with Bihar Rural Livelihoods Promotion Society (BRLPS) to accelerate vaccination of livestock against Peste des […]

The initiative is established by Boehringer Ingelheim and supported by GALVmed Nairobi, Kenya – 4 July 2018– Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, announced today the launch […]

It is a great honour and pleasure for me to have been appointed as the new CEO of GALVmed. I join the organisation at a moment where GALVmed can look […]

GALVmed has received funding approval totalling to US$ 19 million for the Phase 3 programme on Improved Tools for the Control of Animal African Trypanosomosis (Tryps 3). The main objective […]